2022
DOI: 10.1016/j.jiph.2022.06.009
|View full text |Cite
|
Sign up to set email alerts
|

Changing distribution of rotavirus A genotypes circulating in Japanese children with acute gastroenteritis in outpatient clinic, 2014–2020

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
11
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 16 publications
(12 citation statements)
references
References 45 publications
1
11
0
Order By: Relevance
“…The introduction of RV vaccination has succeeded in nearly halving the number of global RV deaths from 453,000 in 2008 to 215,000 in 2013 (Moyo et al, 2014; Tate et al, 2012). Indeed, RV vaccines continue to be successful in minimizing disease severity as well as hospitalizations and thus reducing mortality from RV infection, but the infection nevertheless remains ineradicable, showing multiple outbreaks and greater diversity of circulating RV genotypes in the post-vaccination period documented in our previous studies (Hoque et al, 2020 ; Okitsu et al, 2022 ) as well as by other groups (Gibory et al, 2022 ; Gikonyo et al, 2020 ; Tsugawa et al, 2021 ). A similar diversity of RV genotypes was observed in the present study at SW (Table 1 ).…”
Section: Discussionmentioning
confidence: 78%
See 1 more Smart Citation
“…The introduction of RV vaccination has succeeded in nearly halving the number of global RV deaths from 453,000 in 2008 to 215,000 in 2013 (Moyo et al, 2014; Tate et al, 2012). Indeed, RV vaccines continue to be successful in minimizing disease severity as well as hospitalizations and thus reducing mortality from RV infection, but the infection nevertheless remains ineradicable, showing multiple outbreaks and greater diversity of circulating RV genotypes in the post-vaccination period documented in our previous studies (Hoque et al, 2020 ; Okitsu et al, 2022 ) as well as by other groups (Gibory et al, 2022 ; Gikonyo et al, 2020 ; Tsugawa et al, 2021 ). A similar diversity of RV genotypes was observed in the present study at SW (Table 1 ).…”
Section: Discussionmentioning
confidence: 78%
“…For example, the G3-genotype of RVA remained high in both the pre- and post-pandemic periods in the present study, while the major RVA genotype was G2 in the earlier study (Thongprachum et al, 2018 ). Several clinical data revealed that the G2 genotype dominated in many places in Japan during 2014–2017 (Hoque et al, 2020 ; Khandoker et al, 2018 ), whereas the G3 genotype emerged in the post-vaccine era with an equine-like G3 (eG3) containing the DS-1-like genotype constellation that was firstly reported to cause an outbreak in Japan in Hokkaido in 2016 and then gradually increased (Akane et al, 2021 ; Okitsu et al, 2022 ). Importantly, RVA was detected frequently even after the introduction of RV vaccines in the national immunization program, although the RV-vaccine strains were detected in only 2 SW samples.…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, G8P[8] emerged as a major genotype for the first time in Thailand with the highest incidence rate of 68.4% in 2018–2019 and 81.2% in 2019–2020 (Table 1). Similarly, increasing predominance or outbreaks of G8P[8] out of Thailand were reported during the past decade in several countries, including Japan in 2014–2018 (9.5%–66.0%), 30–34 Korea in 2015–2020 (42.2%), 7 Singapore in 2016 (60.0%), 35 Chile in 2016–2017 (48.0%), 36 the Czech Republic in 2016–2019 (9.3%), 37 Brazil in 2017 (20.0%), 38 Argentina in 2018 (18.1%), 6 Gabon in 2018–2019 (15.0%), 39 and China in 2020–2021 (40.0%) 40 . The emergence of this unusual G8P[8] in Chiang Rai, Thailand may be a consequence of global vaccine introduction, and this phenomenon has been recently described in multiple reports 6,7,30,31,35,38 …”
Section: Discussionmentioning
confidence: 90%
“…In Australia, from 2020 to 2021, a remarkable increase in G8P[8] from 1–87.5% was reported, with a peak in autumn, while the prevalence of G8P[14] decreased from 7.1% to < 1% [ 25 , 26 ]. In a longitudinal study from 2014 to 2020 in Japan, the frequency of G8P[8] increased from 34% in 2017–2018 to 98% in 2018–2019, peaking in the spring [ 27 ]. In Europe, the genotypes G8P[8] and G8P[14] were detected at a prevalence of > 1%, in contrast to previous years [ 28 ].…”
Section: Discussionmentioning
confidence: 99%